2023年5月31日

(Shmulik Dudfur)創新、投資和日本和以色列衛生保健係統的挑戰的中心小組的參與Leor Perl博士,首席創新官Beilinson醫院在Calcalist Israel-Japan會議在東京舉行。Perl博士一起Dov Moran Grove風險投資公司投資的創始人大衛•海勒頂點風險投資公司的管理合夥人,Atsuhiro中川教授,創新實驗室主任仙台東北大學醫院的日本。創造性的解決方案來解決這一問題的老年人口在日本,通過國家之間的文化差異,相互投資,該小組處理日本和以色列之間合作的挑戰和機遇。“這正是日本和以色列文化之間的差異構成特別的沃土獨一無二的合作。以色列帶來的創造力和創業精神,在日本人的秩序和周密的計劃的能力,是一個工會的對比,可能產生偉大的創新,“Leor Perl博士說,首席創新官Beilinson醫院。Perl博士接著說:“我們以色列人善於從項目開始,但不總是在完成它們。我們擅長創意、創業和工作,但事實是,我們沒有在其他領域,日本人擅長。日本知道如何完成項目,他們是優秀的在複雜的工程、生產和發展,他們有一個優秀的行業和工具和經驗來實現願景,事情有時缺乏以色列。”Prof. Atsuhiro Nakagawa, Director of the innovation lab at Tohoku University Hospital in Sendai, Japan, agreed with Dr. Perl's words and said: "There is a lot of room for our nations to learn from each other in the field of innovation in medicine. Caring for Japan's aging population is one of the biggest challenges that Japanese citizens face. I see how buds of the collaboration with Beilinson Hospital could be part of the answer to this challenge. I believe that a synergy based on the strengths of each side will greatly contribute to the development of medical innovation in both countries and hence also to the rest of the world." "The challenge in Israeli-Japanese cooperation will be to understand the cultural differences and use these differences to strengthen the spirit of innovation," said David Heller, Managing Partner at Vertex Ventures. "In terms of an approach to innovation, what characterizes the Israelis is the understanding that mistakes are part of the path to innovation, something that the younger generation in Japan also embraces. Mistakes are an integral part of the process." Later in the panel, mutual investments between Israel and Japan were discussed. One of the successful examples from recent years is the case of Itamar Medical in the field of cardiology, preventive medicine and internal medicine. Israeli company Echo-Care, a provider of senior-care remote monitoring systems, was also discussed. "The basis of every good investment idea is an understanding of a real need that exists, finding a good idea and accurately identifying the people who will make up the team," said Dov Moran. Dr. Perl summarized the discussion and said: "I am grateful for the opportunity to talk with Prof. Atsuhiro, who is actually my counterpart in Japan. I am convinced that the cooperation between Japan and Israel in the field of medical innovation will continue to progress. When Israeli creativity and entrepreneurship join the precision and advanced technology of Japan, the sky's the limit." TAGS